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ABSTRACT
RECREATIONAL PHYSICAL ACTIVITY AND PREMENSTRUAL SYNDROME IN
COLLEGE-AGED WOMEN
MAY 2010
AIMEE KROLL, B.A., MOUNT HOLYOKE COLLEGE
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Elizabeth R. Bertone-Johnson

It is estimated that up to 85% of premenopausal women experience at least one
premenstrual symptom and 15-20% meet clinical criteria for premenstrual syndrome
(PMS). PMS has a high morbidity level and reduces the quality of life for many women
of reproductive age, with pharmaceutical treatments having limited efficacy and
substantial side effects. Physical activity has been recommended as a method of reducing
menstrual symptom severity. However, little evidence exists to support a clear
relationship between physical activity and PMS. Using a cross-sectional design, we
evaluated the relationship between physical activity and PMS and menstrual symptoms
among 186 women aged 18-30 who participated in the University of Massachusetts
Vitamin D Study. PMS and menstrual symptoms were assessed with a modified version
of the Calendar of Premenstrual Experiences. A total of 44 women met established
criteria for PMS, while 46 met criteria for controls. Physical activity was assessed using
a validated questionnaire similar to the one used in the Nurses’ Health Study II. Physical
activity was calculated as metabolic equivalent task-hours (METs) per week. Diet and
other lifestyle factors were assessed by questionnaire. After adjusting for age and
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depression diagnosis, we found that each 10 MET-hour/week increase in physical activity
was associated with a non-significant 3% increase in prevalence of PMS (95% CI: 0.941.14). After adjusting for BMI and percent body fat, results were similar (OR=1.02, 95%
CI: 0.93-1.13). We found no evidence that physical activity was associated with the
occurrence of specific menstrual symptoms among all 186 women. Results do not
support a significant relationship between physical activity and prevalent PMS.
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CHAPTER I
INTRODUCTION
Premenstrual syndrome (PMS) is a condition occurring in the luteal phase of the
menstrual cycle prior to the onset of a woman’s menstrual period. It is estimated that up
to 85% of women who menstruate experience at least one premenstrual symptom,
occurring within the two weeks before menses and easing after menstruation begins.1
PMS is estimated to occur in 8-20% of women and substantially reduces quality of life.2-4
Over 300 PMS symptoms have been described,5 ranging from emotional and behavioral
symptoms such as depression, angry outbursts, irritability, crying spells, anxiety,
confusion, social withdrawal, poor concentration, sleep disturbance, and thirst and
appetite changes, to physical symptoms including breast tenderness, bloating and weight
gain, headache, swelling of the hands or feet, and aches or pains.1
The causes of PMS are not clear. PMS is thought to be caused by an underlying
neurobiological vulnerability to normal fluctuations in the circulating sex hormones
estrogen and progesterone levels during the menstrual cycle.6,7 The role of sex steroids in
PMS is supported by observations that symptoms often improve with treatments resulting
in ovulation suppression.6 In addition, studies suggest that PMS is uncommon in
anovulatory menstrual cycles, and that women with elevated levels of sex hormones have
more severe symptoms.5 Another hypothesis on the etiology of PMS proposes that
emotional and physical symptoms may result from hormonal fluctuations during the
menstrual cycle that alter brain neurotransmitter or neuropeptide function.6,7 In
particular, some studies have observed luteal phase abnormalities in serotonin function in
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women with PMS and a more severe form of PMS, premenstrual dysphoric disorder
(PMDD), compared to symptom free controls. Serotonin levels may be related to
menstrual symptoms including depression, irritability, anger, and increased cravings for
carbohydrates.6 Dietary intake of chocolate, alcohol, sugary drinks, and vitamin B6 have
also been examined for their potential role in PMS, but results are inconclusive.7 Genetic
predisposition to specific symptoms has been suggested by studies examining symptom
occurrence in mother-daughter and twin relationships.5
The diagnostic definition for PMS established by the American College of
Obstetricians and Gynecologists (ACOG), states that symptoms must be present in the 5
days before a woman’s period for at least three menstrual cycles in a row and end within
4 days after her period starts.1 Symptoms must interfere with normal life activities and
may cause impairments in work performance, family and social activities, and sexual
relationships.8 In contrast, the World Health Organization definition does not include
timing, but only states that one symptom be present regardless of severity.8 Because
there are no universally accepted diagnostic criteria, it is difficult to determine accurate
prevalence rates and the impact of symptoms.
Recreational physical activity has been recommended as a method of reducing
PMS occurrence and severity. ACOG recommends aerobic exercise, in particular to
reduce fatigue and depression associated with PMS.1 The U.S. Department of Health and
Human Services recommends regular physical activity as a treatment for PMS9 and some
sources suggest that aerobic exercise is an effective alternative to pharmaceutical
treatments in easing PMS.10 Because the etiology of PMS is still unclear, identifying
modifiable risk factors is important as PMS has such a high morbidity level and reduces
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the quality of life for many women of reproductive age, and pharmaceutical treatments
have limited efficacy and substantial side effects.7
There are several plausible biological mechanisms by which physical activity
could reduce PMS symptoms. Aerobic physical activity may increase endorphin
levels,6,11 decrease levels of estrogen12,13 and other steroid hormones,6 improve transport
of oxygen in muscles,12 reduce cortisol levels,12 and improve psychological wellbeing.11,14 All of these mechanisms support an inverse association of physical activity on
PMS symptoms.
Although physical activity has a multitude of health benefits, its association with
reducing PMS occurrence and symptom severity is not well documented. Previous
observational studies examining this relationship have had inconsistent findings, with
some studies suggesting a protective effect,11,14-20 one showing no association21 and two
studies finding an increased risk of PMS symptoms among exercising women.22,23 One
trial compared physical activity regimens for sedentary and active women;20 however, to
our knowledge, no randomized control trials have included a non-exercising control
group.6 Additionally, several of these studies had sample sizes of fewer than 100 total
subjects.15-17,19 To our knowledge, only one study22 of physical activity and PMS
adjusted for body mass index (BMI), a factor that likely also affects menstrual symptoms.
One study examining obesity and PMS found that the prevalence of symptoms was
significantly higher in obese women compared to underweight women (OR=2.9, 95% CI:
1.1-7.5).24 Failure to control for BMI may thus lead to confounding due to the underlying
relationship between physical activity and BMI.
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Given that PMS etiology is still unclear and there is a need for knowledge of
modifiable risk factors, it is important to determine if physical activity may reduce the
risk of PMS. Therefore, we investigated the relationship between physical activity and
PMS using data from the University of Massachusetts (UMass) Vitamin D Study, a crosssectional study of 186 college-aged women.
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CHAPTER II
PHYSIOLOGY OF PHYSICAL ACTIVITY AND PREMENSTRUAL SYNDROME
PMS occurs during the late luteal phase of the menstrual cycle. On average, one
menstrual cycle lasts 25-36 days beginning with the first day of menstruation. This first
phase of the cycle is known as the follicular phase and occurs on the first day of menses
when estrogen and progesterone levels decrease at the end of the previous cycle.
Following the follicular phase, the ovulatory phase of the cycle begins approximately on
day 13 or 14 with a surge in luteinizing hormone that stimulates the release of an egg
(ovulation). The luteal phase begins after ovulation, and usually lasts approximately 14
days, unless fertilization has occurred 25. PMS occurs during the luteal phase of the
cycle, most often with one week before menses.
There are several biological mechanisms by which physical activity may reduce
the occurrence of PMS. These include an increase in endorphin levels,6,11 a stabilization
of hormone levels and their effect on the hypothalamic-pituitary axes,6,12,13 improvements
to oxygen in muscles,12 and an overall improvement to psychological well-being.11,14
Endorphin levels in the body are the highest during the late follicular phase of the
cycle and tend to decrease during the late luteal and menstrual phases.6,12 Low endorphin
levels may contribute to PMS by decreasing a general overall feeling of wellbeing and
leading to depression and other low emotional states.6 Physical activity has been shown
to increase beta-endorphin levels, which improves mood and thus could reduce emotional
symptoms.6,11
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Physical activity may also improve PMS symptoms by impacting circulating
hormone levels acting on the hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis
is a part of the neuroendocrine system and is involved in regulating many body processes
including digestion, the immune system, mood and emotions, sexuality, energy storage
and expenditure, and stress reduction.26,27 A study by Roca and colleagues (2003) found
that women with PMS did not have a normal increase in HPA axis response following a
treadmill stress test conducted during the luteal phase compared to control women, and
that menstrual cycle related variation in HPA axis function was affected by both
progesterone and estrogen levels.28 These findings suggest that women with PMS have a
decrease in HPA axis response during the symptomatic period, which could contribute to
physical and emotional symptoms.28
Physical activity may also impact the HPA axis by reducing cortisol levels
through a modification to psychological or behavioral reaction to stress. One study found
that women with daily stress and suffering from PMS had higher levels of cortisol than
control subjects,29 while a second study found that women who experienced more stress
on a day-to-day basis (and thus had higher cortisol levels) had more frequent and severe
PMS.30
Other studies have found that physical activity may affect the hypothalamicpituitary-gonadal (HPG) axis causing a decrease to estrogen and progesterone levels,
resulting in fewer menstrual symptoms.6 If physical activity decreases estrogen levels,
this may also impact some of the major neurotransmitters that regulate mood and
behavior, such as serotonin and Gamma Amino Butyric acid (GABA) that are affected by
fluctuating estrogen levels during the luteal phase.5
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Cramping, a common symptom of PMS, is caused by elevated tonic activity of
the myometrium (uterine smooth muscle), which is stimulated by the sympathetic
nervous system. If pain results from hypoxia of the uterine muscle, vasoconstriction
caused by stress (due to the enhanced sympathetic activity that results from
environmental stress) would cause more pain, while physical activity could possibly
alleviate this symptom.12
Physical activity has also been shown to affect a women’s psychological outlook
by improving self-esteem and providing a distraction from other thoughts, which could
provide relief from emotional symptoms associated with PMS.11,14 Increased physical
activity has been found to reduce tension, anger, depression, and low self-esteem, all of
which are symptoms of PMS.12 Physical activity may also improve the functioning of the
immune system, increasing the body’s resistance to stress.14
In summary, there is biological evidence in support of an association between
physical activity and reduction of PMS symptoms through a variety of physiological
mechanisms. These include increases to endorphin levels, helping to maintain the proper
HPA axis response, decreases to sex steroids levels by impacting the HPG axis, reducing
hypoxia of the uterine muscle, and improving emotional and psychological states of
mind.
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CHAPTER III
EPIDEMIOLOGY OF PHYSICAL ACTIVITY AND PREMENSTRUAL SYNDROME
There have been a number of epidemiological studies examining the relationship
between physical activity and PMS. A majority of these studies have found a protective
effect.11,14-19 However, one study showed no association21 and two studies found an
increased risk of PMS symptoms among women who exercised regularly.22,23 All of these
studies were observational except for one nonrandomized intervention study comparing
physical activity regimens for sedentary and active women.20 No randomized control
trials that have included a non-exercising control group have been published.6
Additionally, some of these studies had sample sizes of fewer than 100 women.15-17,19
Due to the cross-sectional design of most of these studies,11,14,16-18,22,23 temporality bias
makes it difficult to determine if exercising is etiologically related in the development of
PMS, or if those with PMS exercised more or less than those without PMS.
Rasheed and colleagues (2003)23 examined the relationship between several
possible risk factors, including physical activity, and PMS among college-aged women in
Saudi Arabia. They conducted a cross-sectional study with 488 women enrolled in
nursing, medical laboratory technology and respiratory therapy educational programs
who were between the ages of 17 and 27. They collected information on risk factors
through a self-administered questionnaire that asked about level of physical activity
(none, daily housework of at least 2 hours, three weekly sessions of walking or
aerobic/rhythmic exercises for at least 20 minutes, or participation in sports). Women
were also asked to report whether they had experienced any of 14 menstrual symptoms
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during the last 6 months for 3 or more cycles within one week prior to the onset of
menstruation. Scores were assigned based on whether the symptom was described as
mild (score=1; daily activities not affected and no medication taken), moderate (score=2;
daily activities not affected but medication was taken), or severe (score=3; daily activities
were affected despite medication). Each woman was assigned a PMS symptom score
from 0 (no symptoms) to 42 (maximum of 14 severe symptoms). The authors found that
96.6% of women in the study reported experiencing at least one menstrual symptom
within the last 6 months. Findings from a univariate analysis show that physically active
women were more likely to have high PMS symptom scores compared to sedentary
women, with 45.3% of physically active women having high ranged scores (10-33)
compared to 30.6% of sedentary women (P<0.01). It is unclear how the women were
divided into physically active and sedentary groups, as there was no description of this
categorization, and no further statistical analysis on the difference between the two
groups was conducted. Due to the cross-sectional design, temporal bias is an issue for
this study, as it is unclear whether women experienced PMS and started or stopped
exercising to alleviate symptoms, or exercised regularly and never experienced PMS.
The total score for PMS symptoms was also arbitrarily categorized into three levels (0, 19, ≥10) without any explanation for this process. Because information was collected by
questionnaire, misclassification of outcome is a limitation of the study as the question on
PMS asked about symptoms during the last 6 months, which can be difficult to remember
at one point in time.
A longitudinal study, conducted by Choi et al.14 examined the relationship
between physical activity and changes in emotional and physical symptoms during the
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menstrual phase to determine if symptoms worsened during the luteal premenstrual
phase. The study included 143 women ages 15-48 from the United Kingdom who were
categorized based on how often they said they exercised each week. Women were
classified as competitive athletes (those training for competitive or public events), high
exercisers (3 or more times per week), low exercisers (less than 3 times per week), or
sedentary. Women were asked to complete a mood questionnaire every night for one
month beginning on the first day of their menstrual cycle and ending on the first day of
their following period, with the premenstrual phase being defined as the 5 days prior to
menstruation. The questionnaire included 42 items describing moods and physical states.
The authors found that during the premenstrual phase, high exercisers had the lowest
mean score for negative affect characteristics including irritability and fatigue, and the
lowest mean score for physical symptoms such as cramps and dizziness. Sedentary
women, low exercisers, and competitive exercisers had higher mean scores than the high
exercisers in all of these groups; however, there was no linear relationship between
physical activity and improved PMS symptoms. One potential limitation of this is study
is the reproducibility of symptom scores over time. Although symptoms were examined
within the 5 days before menstruation, questionnaires were only administered for one
month, and therefore it is difficult to determine whether these symptoms occurred for the
women in every menstrual cycle or only during that month. Because the women knew
that this study was being conducted to examine physical activity and the menstrual cycle,
they may have been more aware of symptoms while filling out the questionnaire than
during an unobserved cycle. This is likely not to differ by physical activity level.
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In one of the first and most cited studies examining physical activity and PMS,
Timonen and Procopé18 recruited 748 women from the Helsinki University in Finland
into a cross-sectional study. They collected data on physical activity and PMS with a 60question survey. The authors compared women who were studying physical education
(n=136) and those in other programs (n=612) with the assumption that those studying
physical education exercised more frequently than those studying other fields. They
found that the percentage of women experiencing premenstrual and menstrual low back
pain, premenstrual and menstrual pelvic pain, premenstrual and menstrual headache,
premenstrual nervousness, irritability, anxiety, depression and fatigue were all
significantly higher (P<0.05) in women studying in other programs compared to those
studying at the Institute of Physical Education. These findings, however, are based on
the assumption that physical education students were more active, though this assumption
was not validated. Other researchers in the field have criticized this study because 54%
of the population was under 22, an age group where anovulation occurs quite frequently
(9-70% of cycles); because only a single cycle was assessed, it was unclear whether
menstrual symptoms were assessed during an ovulatory cycle when symptoms are more
likely to occur.13 Possible confounding by BMI is also an issue.
In summary, previous studies of physical activity and PMS have reported
inconsistent results, with most finding physical activity inversely associated with
menstrual symptom severity. However, limitations of several of the studies that found
this protective effect include recall bias, using different definitions of PMS, and likely
misclassification of physical activity levels. Other studies have had small sample sizes,
and thus had limited power to assess this relationship. To our knowledge, only one study
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in this review adjusted for BMI.22 Our study will use validated physical activity and PMS
assessments, and evaluate many covariates associated with PMS, including BMI.
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CHAPTER IV
SUMMARY
Up to 85% of women who menstruate experience at least one menstrual symptom
two weeks before menstruation begins.1 The ACOG defines PMS as a disorder in which
symptoms are present in the 5 days before a woman’s period begins for at least three
menstrual cycles in a row and that end within 4 days after her period starts, which
substantially interfere with normal life activities.1 Although many prominent
organizations, including the U.S. Department of Health and Human Services,9
recommend physical activity for easing PMS symptoms, there is little conclusive
evidence of a benefit of physical activity. Results of observational studies are
inconsistent and there are clear opportunities for bias and misclassification in studies
examining these two factors. Because the etiology of PMS remains unclear and the
effectiveness of pharmaceutical treatments is limited, knowledge of modifiable risk
factors is important to help alleviate symptoms in women who suffer each cycle.
Physical activity may reduce PMS symptoms through a number of physiological
mechanisms. These mechanisms include increasing endorphin levels, regulating
hormone levels, increasing oxygen supply to the muscles, reducing cortisol levels, and
promoting a less stressful and better outlook on life.
Several epidemiological studies suggest a protective effect of physical activity on
PMS symptoms. Although these studies had several limitations including temporality
bias and misclassifications, they provide some evidence that physical activity may
minimize symptom occurrence.
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Using a cross-sectional design, we examined the association between physical
activity and prevalent PMS using data from the UMass Vitamin D Study. Recreational
physical activity and prevalent PMS was assessed through validated questionnaires in a
group of menstruating college-aged women. We controlled for BMI and several other
possible confounding factors.
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CHAPTER V
HYPOTHESES AND SPECIFIC AIMS
Using a cross-sectional design, we evaluated the relationship between recreational
physical activity and prevalent PMS symptoms among college-aged women. The
following aims were addressed:
Specific Aim 1: To assess the association between physical activity and risk of
PMS.
Hypothesis 1: College-aged women who participate in recreational physical
activity will be less likely to experience PMS than women who do not participate
in recreational physical activity.

Specific Aim 2: To examine the effect BMI has on the relationship between
physical activity and PMS and menstrual symptoms.
Hypothesis 2: Results adjusted for BMI will be stronger than those unadjusted for
BMI.

Specific Aim 3: To examine if physical activity is associated with the occurrence
of specific menstrual symptoms.
Hypothesis 3: Women who participate in more recreational physical activity will
be less likely to experience moderate-severe symptoms compared to women who
participate in less physical activity.
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CHAPTER VI
METHODS
Study Design and Population
This study examined the relationship between physical activity and
PMS/menstrual symptoms using data from the University of Massachusetts (UMass)
Vitamin D Study, a cross-sectional study that was conducted at UMass in Amherst,
Massachusetts between March 2006 and June 2008. The primary purpose of the UMass
Vitamin D Study was to assess factors associated with vitamin D status in young women.
A secondary aim of the study was to assess dietary, lifestyle, and biochemical factors
associated with PMS.
Participants were women aged 18-30. Women were invited to participate in the
study through fliers posted on the UMass campus. Women of all ethnicities were
welcome to participate. Women were ineligible to participate if they: were pregnant or
not currently menstruating; were experiencing untreated depression; reported high blood
pressure or elevated cholesterol, kidney or liver disease, bone disease such as
osteomalacia, digestive disorders, rheumatologic disease, multiple sclerosis, thyroid
disease, hyperparathyroidism, cancer, type 1 or type 2 diabetes, or polycystic ovaries; or
were currently using corticosteroids (such as prednisone, anabolic steroids,
anticonvulsants, Tagmet, Cimetidine, or propranolol). Participants were asked to
complete food-frequency and demographic questionnaires, provide a fasting venous
blood sample (45 mL) drawn in the early morning during the late luteal phase of the
menstrual cycle, and provide a urine sample via a clean catch. The following
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measurements were also taken: fasting blood sugar via glucometer; hemoglobin via
hemoglobinometer; blood pressure; waist circumference; height; weight; and a dual
energy X-ray absorptiometry (DEXA) bone scan to determine body composition and
bone mineral density. Study participation required 1.5 to 2 hours of time to complete the
measurements, and participants were given $10 compensation as well as the results from
the DEXA scan, blood glucose test, and a nutrient analysis of their diet. A total of 186
women participated in the study.

Exposure Assessment
Physical activity was assessed through a self-reported questionnaire. Participants
were asked to report the average time they spent each week over the past month engaging
in specific activities including walking, hiking, jogging, running, bicycling, aerobics or
dancing, tennis or other racket sports, swimming, yoga or Pilates, and weight training.
Response options ranged from zero minutes to 11+ hours per week. Questionnaire
responses were used to calculate metabolic equivalent task (MET) hours per week, which
considers the duration and intensity of physical activity. METs are a measure of energy
expenditure equal to the ratio of metabolic rate at work to resting metabolic rate, and vary
by intensity of a specific type of physical activity. One MET is defined as the energy
expended while sitting quietly.31 We examined physical activity in both continuous
METs per week and in tertiles of METs per week.
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Validity of Exposure Assessment
The questions on physical activity were based on a previous questionnaire used in
the Nurses’ Health Study II (NHSII) and have been previously validated in a population
of 147 young women.32 Test-retest correlation for the questionnaires administered 2years apart were 0.59. Correlation between activity level reported in 7-day activity
diaries and that reported on the questionnaire was 0.62. The types of physical activity
included on the questionnaire were the most common types of physical activity reported
by women in the University of Pennsylvania Alumni Health Study.32

Outcome Assessment
Information on menstrual symptoms was collected through self-reported
questionnaire. Participants were asked to provide information on 26 different symptoms
by responding to the following statement: “For each symptom listed below, please
indicate whether you experience it most months of the year, for at least several days
before your menstrual period begins.” Participants were asked not to include symptoms
that they experienced throughout their entire menstrual cycle, or symptoms that start only
when their period starts. Participants were asked to indicate the usual severity of each
symptom as mild, moderate, severe, or “not at all”. Participants were also asked to
indicate whether their overall severity of symptoms was “minimal” (no effect on normal
activities); “mild” (noticeable, but not troublesome); “moderate” (interferes with normal
activities); or “severe” (intolerable, prevents normal activities).
In addition, women were asked to report the number of days before their period
when symptoms usually began, as well as the number of days the symptoms lasted after
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their period began. Women were then asked to report whether they experienced
relationship discord with family or a partner; relationship discord with friends or
coworkers; poor work performance or attendance; social isolation; and suicidal thoughts,
and to indicate the severity of each of these problems (mild, moderate, or severe).
Finally, women were also asked to report whether they had ever been clinically
diagnosed with PMS.
Responses to the menstrual symptom questionnaire were used to identify women
meeting clinical criteria for PMS based on those developed by Mortola et al.33 A woman
was considered a case if she reported: 1) at least one physical and one affective menstrual
symptom; 2) overall symptom severity of “moderate” or “severe”, impact of symptoms
on life activities and relationships of “moderate” or “severe”, or one or more individual
symptoms rated as “severe”; 3) symptoms beginning within 14 days of the start of
menses; 4) symptoms ending within 4 days of the start of menses; and 5) symptoms are
absent in the week after menses. The menstrual symptom questionnaire was also used to
identify women with few or no menstrual symptoms to serve as controls. Controls were
women who reported: 1) overall symptom severity of “none” or “mild” for all individual
symptoms; 2) overall symptom severity of “none”, “minimal” or “mild”; 3) impact of
symptoms on life activities and relationships of “not a problem” or “mild” for all items;
and 4) no previous clinical diagnosis of PMS.

Validity of Outcome Assessment
The questionnaire used for this study to assess PMS is based on the Calendar of
Premenstrual Experiences designed by Mortola et al.33 and similar to that used in the
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NHSII.34 A validation study on the questionnaire used in the NHSII showed that
menstrual symptom timing, occurrence, and severity in PMS cases identified with those
criteria were similar for women who reported that the “gold standard” of prospective
symptom charting had been used in making their diagnosis.34

Covariate Assessment
Covariate information was collected through a self-reported questionnaire
measuring factors including age, age at first menstruation, current oral contraceptive use,
smoking status, marijuana use, hours of sleep per weeknight, history of reproductive tract
infections, and history of depression or bipolar disorder. Results from the food frequency
questionnaire were used to determine intake of vitamin D and calcium from food sources
as well as daily alcohol consumption. Body composition was measured by study staff
through use of a DEXA scan. Height and weight were measured directly and used to
calculate BMI (weight [kg]\height [m]2).

Data Analysis Plan
Specific Aim 1: To assess the association between physical activity and risk of PMS.

Univariate Analysis
We calculated the number and percent of subjects based on PMS status as well as
by tertile of METs/week of physical activity. We also calculated the distribution of
physical activity in METs/week based on PMS status.
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Bivariate Analysis
We cross-tabulated covariates with outcome and exposure variables to evaluate
potential confounders. We also cross-tabulated continuous covariates with PMS status in
a separate analysis. Cross-tabulations were evaluated using a chi-square test to determine
if the observed distribution fit the expected distribution when the cell size was sufficient,
and with Fisher’s Exact test if cell counts were small (<5).

Multivariate Analysis
The relationship between physical activity and PMS was modeled using
multivariable logistic regression. Two analyses were conducted; the first examined
physical activity categorized into tertiles of MET-hours/week, the second examined
continuous physical activity in units of 10 MET-hours/week as the exposure. We
calculated odds ratios (ORs) and 95% confidence intervals (95% CI).
Confounders were evaluated by examining the physical activity/PMS relationship
by running the model with each covariate separately. Any covariate whose addition to
the model changed the odds ratio by 10% or more was retained in the model as a
confounder.

Specific Aim 2: To examine the effect BMI has on the relationship between physical
activity and PMS and menstrual symptoms.
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Multivariate Analysis
Confounding by BMI and percent body fat were examined by evaluating the
physical activity/PMS relationship in regression models with and without these variables
and comparing odds ratios between the models. Effect modification was assessed by
stratifying our population by BMI (<22.5 vs. ≥ 22.5 kg/m2) and then calculating stratum
specific odds ratios for the relationship between continuous BMI and PMS. We then
created a multiplicative interaction term (continuous physical activity*BMI strata) and
included this term in the multivariable regression model along with terms for continuous
physical activity and BMI. The Wald P-value for the interaction terms was used to assess
whether interaction was significant (P<0.05).

Specific Aim 3: To examine if physical activity is associated with the occurrence of
specific menstrual symptoms.

Multivariate Analysis
The relationship between physical activity and PMS symptoms was modeled
using multivariable logistic regression. For this analysis, we evaluated continuous levels
of physical activity, in 10 MET-hours/week. Symptoms were dichotomized into
none/mild or moderate/severe, based on the previously identified criteria. We included
those covariates identified as confounders in the main analysis.

The data analysis for this paper was performed using SAS software, Version 9.2 for
Windows (SAS Institute Inc., Cary, NC, USA).
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CHAPTER VII
SIGNIFICANCE
Previously published studies on physical activity and PMS have reported
inconsistent results. Because physical activity is a potential modifiable risk factor for a
condition that affects many women, additional research to evaluate this relationship is
important. Results from this study could help inform future research and randomized
trials that examine exercise and PMS. The results could also be used to help modify
current guidelines recommending exercise as a treatment for PMS and menstrual
symptoms.
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CHAPTER VIII
HUMAN SUBJECT PROTECTION
The Vitamin D Study was approved by the Institutional Review Board at UMass
Amherst in Amherst, Massachusetts. All participants were required to sign informed
consent documents prior to their participation, the completion of questionnaires, or
biologic sample collection. Participants were provided specific information about
confidentiality and told that they are allowed to withdraw from the study at any time.
All participant personal information, including questionnaires, biologic samples,
and clinical measurements are kept in a secure location in the UMass Vitamin D Study
office at the School of Public Health UMass Amherst. All participant names and ID’s are
stored in locked filing cabinets separate from study data to maintain confidentiality.
Questionnaires and all data are identified by ID numbers only. All computerized
documents are password protected.
There are no known risks to the study participants, except for the possibility of
discomfort associated with having blood pressure taken, blood drawn, urine collected,
undergoing studies of genetic factors, or undergoing a DEXA scan. As mentioned
earlier, the participant can withdraw at any time, also preventing any emotional distress
that may occur. Accidental breach of confidentiality is highly unlikely to occur, as
security procedures are maintained for every document involved in the study. There are
no known benefits to the participants, except for receiving their $10 compensation as well
as the results from the DEXA scan, blood glucose test, and a nutrient analysis of their
diet. Data are used for medical statistical purposes only.
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CHAPTER IX
PERMISSION TO ACCESS DATA
I, Aimee Kroll, have been granted permission to use the data from the UMass Vitamin D
study by the co-Principal Investigator of the Vitamin D Study, Elizabeth BertoneJohnson, for the purposes of this thesis.

Signed:

___________________________________
Elizabeth R. Bertone-Johnson, ScD

___________________________________
Aimee Kroll
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CHAPTER X
RESULTS
Table 2 shows the distribution of PMS status by study participants for those that
met either the case or control criteria. About half (49%) of the total 186 participants met
either one of these definitions, with 44 meeting case criteria and 46 meeting control
criteria. Table 3 shows the distribution of participants by physical activity tertile for all
186 study participants. The ranges of MET values in our population was relatively large,
with women in the highest tertile reporting at least 65 MET-hours per week. Table 4
shows the distribution of PMS cases and controls by physical activity tertile.
Characteristics of PMS cases and controls are presented in Table 5. A total of 4%
of controls reported that they had ever smoked, compared to 30% of cases (P=0.001).
For marijuana smoking, 17% of controls reported ever smoking marijuana compared to
32% of cases (P=0.11). Vitamin D status also differed between cases and controls, with
64% of cases and 83% of controls reporting intake from food sources over 100 IU/day or
more (P=0.04). Intake of calcium from food sources had a similar pattern, with 58% of
controls in the highest intake group (>1200 mg/day) and only 21% of cases (P=0.06).
Age, age at first menses, BMI, alcohol consumption, hours of sleep per weeknight,
current oral contraceptive use, history of reproductive tract infections, diagnosis of
depression or bipolar disorder, and percent body fat did not differ significantly between
cases and controls. Cases and controls also had similar mean values for age, age at first
menses, BMI, alcohol consumption, vitamin D intake, calcium intake, and percent body
fat (Table 6).
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When examining the distribution of covariates by physical activity tertile (Table
7), fewer women in the highest tertile were ever smokers or had their first menses before
the age of 12 than in the lower two tertiles, though these differences were not significant.
For example, 8% of women in the highest tertile were ever smokers compared to 17% in
tertile 2 and 13% in tertile 1 (P=0.31). Current oral contraceptive use significantly
differed between tertiles, with 28% of women in the highest tertile currently using oral
contraceptives compared to 51% in tertile 2 and 39% in tertile 1 (P=0.03). Women in the
highest tertile of physical activity consumed greater amounts of calcium when compared
to women in the lower two tertiles (>1200 mg/day: Tertile 3- 46%; Tertile 2- 24%;
Tertile 1- 21%) (P=0.01). Distribution of age, BMI, alcohol consumption, hours of sleep
per weeknight, marijuana use, history of reproductive tract infections, diagnosis of
depression or bipolar disorder, vitamin D intake, and percent body fat were similar across
all three tertiles.
In unadjusted analyses physical activity was not associated with PMS. Women in
tertile 2 had a non-significant 59% increased risk of PMS compared to women in tertile 1
(95% CI: 0.59-4.33) and women in tertile 3 had a non-significant 53% increased risk of
PMS compared to women in tertile 1 (95% CI: 0.53-4.34). Results were similar after
controlling for age and history of depression or bipolar disorder; the OR for women in
tertile 2 versus tertile 1 was 1.62 (95% CI: 0.58-4.51) while the odds ratio for tertile 3
versus tertile 1 was 1.67 (95% CI: 0.57-4.92). When examining the association between
continuous level of physical activity (per 10 MET-hours/week) and PMS, the
multivariable odds ratio was 1.03 (95% CI: 0.94-1.14), where every 10 MET-hour/week
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increase in physical activity corresponds to a non-significant 3% increase in PMS (Table
8).
Secondly, we were interested in examining the effect of adjustment for BMI and
percent body fat on multivariable odds ratios. We included BMI as a measure of body
mass, and included percent body fat from the DEXA scan as a measure of lean body
mass. Table 9 shows four multivariable models: 1) not including BMI or percent body
fat; 2) including only BMI; 3) including only percent body fat; and 4) including both
BMI and percent body fat. There was no significant change in the odds ratios for
physical activity among the four models, indicating that neither BMI nor percent body fat
confounded the relationship between physical activity and PMS. When examining the
relation between each 10 MET-hour/week change in physical activity and PMS risk, odds
ratios and 95% confidence intervals were also similar for all four multivariable models
(Table 9).
We also examined if BMI modified the relationship between physical activity and
PMS. We found no significant difference in the relationship between continuous level of
physical activity and PMS between strata. The odds ratio for women in the lower BMI
category (<22.5 kg/m2) was 1.06 (95% CI: 0.90-1.26) while the odds ratio in the higher
BMI category (≥22.5 kg/m2) was 1.01 (95% CI: 0.89-1.15) (Table 10). The P-value for
interaction was 0.68.
We then examined the association between each 10 MET-hour/week change in
physical activity and the occurrence of 26 specific menstrual symptoms, with our
outcome being moderate-severe severity versus none-mild severity for each symptom
(Table 11). All models were adjusted for age and history of depression or bipolar
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disorder. Every 10 MET-hour/week increase in physical activity was associated with a
13% lower risk of headache (OR=0.87, 95% CI: 0.74-1.01); a 5% increased risk of food
cravings, changes in appetite, irritability and emotional hypersensitivity (OR=1.05, 95%
CI: 0.99-1.11); and a 10% increase in risk of forgetfulness (OR=1.10, 95% CI: 1.001.21).
In additional analyses, we examined the association between meeting
recommended physical activity guidelines and risk of PMS. Current guidelines
recommend at least 30 minutes of moderate intensity physical activity on most days of
the week, corresponding to 10 MET-hours/week (0.5 hr * 4 METs * 5 days = 10 METhrs/week).35 We found no evidence in decrease of risk in women who met this
recommended criteria compared to those who did not meet the recommended physical
activity criteria, either in unadjusted models or after adjusting for age and diagnosis of
depression or bipolar disorder (multivariable OR=1.11, 95% CI: 0.31-3.99).

29

CHAPTER XI
DISCUSSION
In this cross-sectional study of 186 premenopausal women, we found no
association of physical activity with PMS or menstrual symptoms. Results from age and
history of depression or bipolar disorder adjusted models were also null. Physical
activity modestly but non-significantly increased risk of moderate to severe food
cravings, changes in appetite, irritability, emotional hypersensitivity and forgetfulness
and reduced the risk of headache.
Unlike prior studies,11,14-18,20 we found no significant decrease in risk of PMS or
menstrual symptoms in women who were more physically active compared to women
who were not physically active or who were less physically active. We observed no
substantial association even after adjusting for BMI and percent body fat, which gave us
a representation of lean body mass for each participant. However, our sample size was
small and confidence intervals were wide, possible explaining our lack of significant
findings. Given our small sample size, our power for the study was relatively low, with
80% power to detect an odds ratio of 2.7. It is possible that with a larger sample size, we
may have had more power to detect a modest association. The range of physical activity
in our study population may have also affected our results. Because the physical activity
range was so high, we did not have enough power to examine substantially low activity
women compared to high activity women, another possible explanation for our null
findings.
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Two previous studies22,23 found an increased risk of PMS for physically active
versus inactive women. Deuster et al. found that 10% of highly active women
experienced PMS compared to 4.7% of inactive women, and inactive women had a
significant 60% reduction in PMS symptoms (95% CI: 0.2-0.7) after adjustment for race,
age, age at menarche, smoking, BMI, alcoholic drinks, and nutritional habits among other
factors.22 Rasheed et al. showed that 45.3% of physically active women had high
premenstrual symptom scores compared to 30.6% of sedentary women based on a selfreported questionnaire on symptom severity.23 Both of these studies were similar to ours
by cross-sectional design and questionnaires that determined physical activity status and
PMS and menstrual symptom severity.
It is possible that our results were affected by bias. Nondifferential
misclassification of exposure may arise if physical activity is measured inaccurately,
independent of PMS assessment. Because physical activity was measured through a selfreported questionnaire, it is possible that women under or over reported their physical
activity, did not report on specific activities, or participate more in occupational or
lifestyle physical activity compared to recreational activity. Any nondifferential
misclassification of exposure that occurred will bias the results toward the null, therefore
making any association weaker. However, we used a questionnaire that has been
previously validated through comparisons with physical activity diaries, making it
unlikely that any nondifferential misclassification of exposure would bias our results
substantially.32
Nondifferential misclassification of outcome could occur if PMS and menstrual
symptoms were measured inaccurately. Because menstrual symptoms were measured

31

with a self-reported questionnaire, it is possible that some nondifferential
misclassification of outcome could occur, independent of physical activity assessment.
Women may under or over report symptoms or severity of symptoms, not report on
specific symptoms, or may have been unclear about the definition of symptom severity.
However, we asked women about their usual menstrual symptoms, making it easier to
recall specific symptoms and their severity if they occur each month, opposed to
questions asking about a specific time period. Any nondifferential misclassification of
outcome that occurred would have biased our results closer to the null.
Selection bias, in the form of non-comparable selection, may have occurred if
women who experience PMS and are physically active were more motivated to
participate in the study than other women, or if women who do not experience PMS
symptoms and are not physically active were less motivated to participate. If women
who have severe PMS and participate in high amounts of physical activity were more
likely to join the study because they wanted to know what causes their symptoms, our
results would be overestimated if exercise truly reduces PMS. However, because the
study was conducted primarily to look at vitamin D status, women agreeing to participate
in the study were unlikely to make a connection between questions asking about PMS
and physical activity habits.
Information bias may occur in the form of recall bias if women who experience
PMS and menstrual symptoms are more motivated to accurately report their physical
activity habits compared to women who do not experience PMS. This is unlikely in our
study, because as noted earlier the study’s primary objective was to assess vitamin D
status. It is unlikely that a participant could know that an association between physical
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activity and PMS would be examined as the questions on the questionnaire were in
separate unrelated sections. However, because physical activity is often recommended to
help alleviate PMS, a woman may nonetheless make this connection. Because the
questions on PMS come before the questions on physical activity in our study
questionnaire, a woman who answered the questions on PMS and felt like it was an
important issue based on her responses may be more likely to recall her physical activity
differently compared to a woman who did not notice a trend with her questions on the
PMS section. In this situation, a woman may underreport her physical activity if she
believes she does not participate in enough physical activity to help ease menstrual
symptoms and PMS. If this type of information bias did occur in our study, our results
would be underestimated because she would be considered unexposed and experiencing
PMS.
In a cross-sectional study, it is often difficult to determine whether the exposure
preceded the outcome or vice versa. In our study, we are unable to know if women
experiencing PMS started exercising to help alleviate symptoms, if women who have
been exercising regularly do not experience PMS symptoms because of the physical
activity, or if women who experience PMS do not participate in physical activity because
their symptoms are so severe they do not feel well enough to exercise. Temporality bias
in our study will bias our results depending on the scenario. If exercise is protective then
we assume that cases exercise less than controls. If a case starts exercising more to treat
her symptoms, she thus increases her exposure level and makes the overall level in cases
more similar to controls, therefore biasing our results toward the null. In another
example, if a case who has been exercising stops exercising because her symptoms are
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severe, she thus decreases her exercise level and makes the overall level of activity in the
cases even lower and more different from controls, therefore biasing our results away
from null, making exercise look more protective.
Survival bias in a cross-sectional study can occur if people who are exposed are
more likely to die due to the outcome. Because there is no risk of mortality from physical
activity or PMS, this type of bias is not a concern in our study.
It is possible that there was some residual confounding that affected our results in
either direction depending on the type of confounding variable. An example of a
confounder that we did not collect data on is stress. Stress has been shown to be
associated with a greater risk of PMS.22 Confounding by stress could exist in two
separate scenarios. If stress caused a woman to participate in more physical activity as a
means of alleviating stress, and stress was the true cause of PMS, less PMS would be
attributed to her physical activity, not the reduction of her stress, therefore biasing an
inverse association to the null. Likewise, if a woman who experienced stress exercised
less because she felt like she had too many other things to do, her PMS would bias an
inverse association away from the null. Although stress may play a role in our findings,
we believe that women who are under a great deal of stress probably would not take the
time to participate in this study, therefore making this situation unlikely to affect our
results substantially.
Another potential limitation of our study is using multiple comparisons to
examine the relationship between physical activity and specific menstrual symptoms. We
did not adjust for multiple comparisons in our analysis. However, doing so would not
have had much affect on our results as they were null.
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The results of our study could be applicable to premenopausal women, as the
biological mechanisms that relate physical activity to PMS likely do not vary by race or
ethnic origin.
In conclusion, we found no association with physical activity and the occurrence
of PMS and menstrual symptoms. It is possible that our cross-sectional design led to
several biases and that the temporal relationship between physical activity and PMS
could not be examined in a cross-sectional study. The relationship between physical
activity and PMS remains unclear. Further research in the form of prospective studies
and randomized trials, to minimize biases associated with cross-sectional studies, should
be conducted in this area before concluding that physical activity and PMS are
associated.
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TABLES
Table 1: Classification of Study Variables
Name
bloat

tender
dizzy
head
hot
naus
swell
acne
const
crave
palp
anx
appet
irrit
hyper
fatig

Description
PMS symptom: Abdominal bloating
• 1 = Not at all
• 2 = Mild
• 3 = Moderate
• 4 = Severe
PMS symptom: Breast tenderness
• Categories as for variable “bloat,”
above
PMS symptom: Dizziness
• Categories as for variable “bloat,”
above
PMS symptom: Headache
• Categories as for variable “bloat,”
above
PMS symptom: Hot flashes
• Categories as for variable “bloat,”
above
PMS symptom: Nausea
• Categories as for variable “bloat,”
above
PMS symptom: Swelling in extremities
• Categories as for variable “bloat,”
above
PMS symptom: Acne
• Categories as for variable “bloat,”
above
PMS symptom: Diarrhea/constipation
• Categories as for variable “bloat,”
above
PMS symptom: Food cravings
• Categories as for variable “bloat,”
above
PMS symptom: Palpitations
• Categories as for variable “bloat,”
above
PMS symptom: Anxiety/nervousness
• Categories as for variable “bloat,”
above
PMS symptom: Increased/decreased appetite
• Categories as for variable “bloat,”
above
PMS symptom: Irritability
• Categories as for variable “bloat,”
above
PMS symptom: Emotional hypersensitivity
• Categories as for variable “bloat,”
above
PMS symptom: Fatigue
• Categories as for variable “bloat,”
above
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Type
Categorical

Variable Group
Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

mood
cry
insom
angry
alone
depres
confus
forget
cramp
back
pms
pa_tot
patert
METS10
age_m

curr_oc

cur_smk

PMS symptom: Mood swings
• Categories as for variable “bloat,”
above
PMS symptom: Tendency to cry easily
• Categories as for variable “bloat,”
above
PMS symptom: Insomnia
• Categories as for variable “bloat,”
above
PMS symptom: Angry outbursts
• Categories as for variable “bloat,”
above
PMS symptom: Desire to be alone
• Categories as for variable “bloat,”
above
PMS symptom: Depression
• Categories as for variable “bloat,”
above
PMS symptom: Confusion
• Categories as for variable “bloat,”
above
PMS symptom: Forgetfulness
• Categories as for variable “bloat,”
above
PMS symptom: Abdominal cramping
• Categories as for variable “bloat,”
above
PMS symptom: Lower back pain
• Categories as for variable “bloat,”
above
PMS symptom: Lower back pain
• 1 = Case
• 0 = Control
Recreational activity: MET hours/week
Recreational physical activity: Tertiles
Recreational activity: 10 MET hours/week
Age menstrual periods began
• 1 = ≤ 9 years old
• 2 = 10 years old
• 3 = 11 years old
• 4 = 12 years old
• 5 = 13 years old
• 6 = 14 years old
• 7 = 15 years old
• 8 = 16 years old
• 9 = ≥ 17 years old
Currently using OCs
• 1 = Yes
• 0 = No
• 99 = blank
Currently smoke
• 1 = Yes
• 0 = No
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Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Categorical

Outcome

Continuous
Categorical
Continuous
Categorical

Exposure
Exposure
Exposure
Covariate

Categorical

Covariate

Categorical

Covariate

smk_mar
alco
ill

wd_slp

rti

vitd_wo
calc_wo
Bodyfat
Bmi
Agequart

Men_age
bmicat_a

Do you smoke marijuana
• 1 = Yes
• 0 = No
Alcohol consumption in grams per day
Ever had any of the following cliniciandiagnosed illnesses (mark all that apply)
• 1 = Lactose intolerance
• 2 = Depression (unipolar depression)
• 3 = Bipolar disorder (manic
depressive illness)
• 4 = Endometriosis
• 5 = Uterine fibroids
• 6 = None of the above
On an average weekday, how many hours do
you sleep per night?
• 1 = ≤3 hours
• 2 = 4-5 hours
• 3 = 6-7 hours
• 4 = 8-9 hours
• 5 = ≥10 hours
In the past 6 months, have you been treated by
a healthcare provider/ treated yourself for any
of the following reproductive tract infections
(mark all that apply)
• 1 = Bacterial vaginosis (BV)
• 2 = Yeast
• 3 = Chlamydia
• 4 = Gonorrhea
• 5 = Trichomoniasis
• 6 = Syphilis
• 7 = Genital warts
• 8 = Genital herpes
• 9 = Not sure
• 10 = None of the above
• 99 = missing
Vitamin D intake per day (IU) from food
sources
Calcium intake per day (mg) from food
sources
% Body fat from DEXA
BMI Calculated
Age quartiles:
• 1 = 18-18.99
• 2 = 19-20.99
• 3 = 21-22.99
• 4 = ≥23
Age at first menstruation:
• 1 = ≤12
• 2 = >12
BMI categories:
• 1 = 16.5-24.9
• 2 = ≥25
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Categorical

Covariate

Continuous
Categorical

Covariate
Covariate

Categorical

Covariate

Categorical

Covariate

Continuous

Covariate

Continuous

Covariate

Continuous
Continuous
Categorical

Covariate
Covariate
Covariate

Categorical

Covariate

Categorical

Covariate

Alcocat

Wd_slp
rticat

Illcat
Vitdcat

Calccat

Bodyfatq

Alcohol consumption:
• 1=0
• 2 = 0.88-3.07
• 3 = 3.08-7.92
• 4 = 7.93-69.78
Weekday sleep (hours):
• 1 = 4-7
• 2 = ≥8
History of reproductive tract infection:
• 1 = Yes
• 0 = No
• 2 = Missing
Diagnosis of depression or bipolar disorder:
• 1 = Yes
• 0 = No
Vitamin D intake:
• 1 = <100
• 2 = ≥100
Calcium intake:
• 1 = 0-599
• 2 = 600-1200
• 3 = >1200
Body fat quartiles:
• 1 = 14.5-26.1
• 2 = 26.2-31.6
• 3 = 31.7-37.3
• 4 = 37.4-50.1
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Categorical

Covariate

Categorical

Covariate

Categorical

Covariate

Categorical

Covariate

Categorical

Covariate

Categorical

Covariate

Categorical

Covariate

Table 2: Distribution of PMS Status among Study Participants (n=186)
N
%
PMS Case
44
24
PMS Control
46
25
Total
90
49
Table 3: Distribution of Physical Activity Status among Study Participants (n=186)
N
%
Median
Range
Physical activity tertile 1
62
33
16.1
0-23.9
Physical activity tertile 2
63
34
42.8
24.1-65.1
Physical activity tertile 3
61
33
100.3
65.4-374.2
*Median and range in MET-hours/week
Table 4: Distribution of Physical Activity Status among PMS Cases and Controls (n=90)
Physical Activity
Physical Activity
Physical Activity
Tertile 1
Tertile 2
Tertile 3
N (% of tertile)
N (% of tertile)
N (% tertile)
PMS Case
12 (19)
18 (28)
14 (23)
PMS Control
17 (27)
16 (25)
13 (21)
Total
29 (46)
34 (53)
27 (44)
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Table 5: Distribution of Categorical Covariates According to PMS Status, among Cases
and Controls (n=90)*

Age
18
19-20
21-22
23-30
Age at first menses
≤12
>12
BMI (kg/m2)
16.5-24.9
≥25
Current alcohol intake (grams/day)
0
0.88-3.07
3.08-7.92
7.93-69.78
Hours of sleep per weeknight
4-7
≥8
Current oral contraceptive use
Yes
No
Ever Smoker
Yes
No
Marijuana use (any)
Yes
No
History of reproductive tract infections in the
past 6 months
Yes
No
Previous diagnosis of depression or bipolar
disorder
Yes
No
Vitamin D intake from food sources only
(IU/day)
<100
≥100
Calcium intake from food sources only
(mg/day)
0-599
600-1200
>1200
Percent body fat measured with DEXA scan
14.5-26.1
26.2-31.6
31.7-37.3
37.4-50.1

PMS Case
(n=44)
N (%)

PMS Control
(n=46)
N (%)

6 (14)
16 (36)
13 (30)
9 (20)

9 (20)
19 (41)
10 (22)
8 (17)

25 (57)
19 (43)

20 (43)
26 (57)

0.21

35 (80)
9 (20)

37 (80)
9 (20)

0.92

5 (11)
12 (27)
15 (34)
12 (27)

11 (24)
15 (32)
10 (22)
10 (22)

35 (80)
9 (20)

31 (67)
15 (33)

0.19

19 (44)
25 (56)

17 (37)
29 (63)

0.55

13 (30)
31 (70)

2 (4)
44 (96)

0.001

14 (32)
30 (68)

8 (17)
38 (83)

0.11

2 (5)
35 (79)

2 (4)
39 (85)

0.38

8 (18)
36 (82)

4 (9)
42 (91)

0.19

16 (36)
28 (64)

8 (17)
38 (83)

0.04

15 (34)
20 (45)
9 (21)

6 (13)
27 (59)
13 (58)

10 (23)
13 (30)
13 (30)
7 (17)

14 (30)
12 (26)
8 (18)
12 (26)

*Numbers may not add up to 44 cases and 46 controls due to missing data
**P-values from χ2 test and Fisher’s exact test (when cell sizes were <5)
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P-value**

0.74

0.29

0.06

0.37

Table 6: Distribution of Continuous Covariates According to PMS Status, among Cases
and Controls (n=90)
Cases (n=44)
Mean (SD)
21.9 (3.4)
12.4 (1.4)
22.8 (2.9)
6.8 (6.8)
188.4 (166.9)
880.2 (377.4)
30.4 (7.3)

Age (year)
Age at first menses (year)
BMI (kg/m2)
Current alcohol intake (grams/day)
Vitamin D intake from food sources only (IU/day)
Calcium intake from food sources only (mg/day)
Percent body fat
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Controls (n=46)
Mean (SD)
21.5 (3.5)
12.7 (1.2)
22.2 (3.2)
5.1 (7.8)
209.6 (145.7)
954.8 (383.2)
31.0 (8.4)

P-value
(Student’s t-test)
0.56
0.34
0.40
0.27
0.52
0.36
0.76

Table 7: Distribution of Covariates According to Physical Activity Status in all
Participants (n=186)*

Age
18
19-20
21-22
23-30
Age at first menses
≤12
>12
BMI (kg/m2)
16.5-24.9
≥25
Current alcohol intake (grams/day)
0
0.88-3.07
3.08-7.92
7.93-69.78
Hours of sleep per weeknight
4-7
≥8
Current oral contraceptive use
Yes
No
Ever Smoker
Yes
No
Marijuana use (any)
Yes
No
History of reproductive tract infections in
the past 6 months
Yes
No
Previous diagnosis of depression or bipolar
disorder
Yes
No
Vitamin D intake from food sources only
(IU/day)
<100
≥100
Calcium intake from food sources only
(mg/day)
0-599
600-1200
>1200
Percent body fat measured with DEXA scan
14.5-26.1
26.2-31.6
31.7-37.3
37.4-50.1

Tertile 1 (n=62)
Median=16.1
(MET-hrs/wk)

Tertile 2 (n=63)
Median=42.8
(MET-hrs/wk)

Tertile 3 (n=61)
Median=100.3
(MET-hrs/wk)

N (%)

N (%)

N (%)

11 (18)
28 (45)
9 (15)
14 (22)

9 (14)
27 (43)
13 (21)
14 (22)

8 (13)
28 (46)
17 (28)
8 (13)

36 (58)
26 (42)

35 (56)
28 (44)

26 (43)
35 (57)

0.18

45 (74)
16 (26)

51 (81)
12 (19)

43 (70)
18 (30)

0.39

10 (16)
25 (40)
11 (18)
16 (26)

16 (25)
14 (22)
17 (27)
16 (25)

13 (21)
14 (23)
18 (30)
16 (26)

46 (74)
16 (26)

38 (60)
25 (40)

46 (77)
14 (23)

0.10

24 (39)
38 (61)

32 (51)
31 (49)

17 (28)
44 (72)

0.03

8 (13)
54 (87)

11 (17)
52 (83)

5 (8)
56 (92)

0.31

16 (26)
46 (74)

16 (25)
47 (75)

14 (23)
47 (77)

0.92

4 (8)
49 (92)

4 (8)
49 (92)

2 (4)
48 (96)

0.77

10 (16)
52 (84)

8 (13)
55 (87)

5 (8)
56 (92)

0.41

17 (27)
45 (73)

14 (22)
49 (78)

12 (20)
49 (80)

9 (14)
40 (65)
13 (21)

14 (22)
34 (54)
15 (24)

7 (11)
26 (43)
28 (46)

12 (21)
11( 19)
15 (26)
20 (34)

16 (26)
14 (23)
17 (28)
14 (23)

14 (24)
21 (36)
13 (22)
10 (17)

P-value**

0.54

0.25

0.58

0.01

*Numbers may not add up to their respective tertile size due to missing data
**P-values from χ2 test and Fisher’s exact test (when cell sizes were <5)
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0.24

Table 8: Odds Ratios and 95% Confidence Intervals for the Association of Physical
Activity and PMS, among Cases and Controls (n=90)
Physical activity
(Median)
Tertile 1 (16.1)
Tertile 2 (42.8)
Tertile 3 (100.3)

Physical Activity
(per 10 METhours/week)

Cases (N)

Controls (N)

12
18
14

17
16
13

Cases (N)

Controls (N)

44

46

Unadjusted
OR
95% CI

Multivariable*
OR
95% CI

1.00
1.59
1.53

1.00
1.62
1.67

Referent
0.58-4.51
0.57-4.92

Unadjusted
OR
95% CI

Multivariable*
OR
95% CI

1.03

1.03

*Adjusted for age and history of depression/bipolar disorder

44

Referent
0.59-4.33
0.53-4.34

0.94-1.13

0.94-1.14

Table 9: Multivariable* Odds Ratios and 95% Confidence Intervals for the Association of
Physical Activity and PMS, with and without BMI and Percent Body Fat Included,
among Cases and Controls (n=90)

Physical
activity
Tertile 1
Tertile 2
Tertile 3

Continuous
physical
activity
(per 10 METhours/week)

Multivariable:
Not including BMI
or % body fat
OR
95% CI

OR

95% CI

OR

95% CI

Multivariable:
with BMI and %
body fat
OR
95% CI

1.00
1.62
1.67

1.00
1.67
1.62

Referent
0.59-4.68
0.55-4.82

1.00
1.73
1.82

Referent
0.60-4.95
0.60-5.47

1.00
1.71
1.56

Referent
0.58-4.51
0.57-4.92

Multivariable:
with BMI

Multivariable:
with % body fat

Referent
0.59-4.94
0.50-4.87

Multivariable:
Not including BMI
or % body fat
OR
95% CI

OR

95% CI

OR

95% CI

Multivariable:
with BMI and %
body fat
OR
95% CI

1.03

1.03

0.94-1.14

1.04

0.94-1.14

1.02

0.94-1.14

Multivariable:
with BMI

Multivariable:
with % body fat

*Adjusted for age and history of depression/bipolar disorder
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0.93-1.13

Table 10: Multivariable* Odds Ratios and 95% Confidence Intervals for the Association
of Physical Activity and PMS, by Category of BMI**, among Cases and Controls (n=90)
Lower BMI
<22.5 kg/m2
Continuous
physical activity
(per 10 METhours/week)

Higher BMI
≥22.5 kg/m2

OR

95% CI

OR

95% CI

1.06

0.90-1.26

1.01

0.89-1.15

*Adjusted for age and history of depression/bipolar disorder
**P-value for interaction = 0.68
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Table 11: Multivariable* Odds Ratios and 95% Confidence Intervals of the Association
Between Levels of Physical Activity** and Occurrence of Specific Menstrual
Symptoms***, among All Participants (n=186)
β
Symptom
OR (95% CI)
P-value
0.10
1.10 (1.00-1.21)
0.04
Forgetfulness
0.05
1.05 (0.99-1.11)
0.09
Food cravings
0.04
1.05 (0.99-1.11)
0.12
Increased/decreased appetite
0.05
1.05 (0.99-1.11)
0.08
Irritability
0.05
1.05 (0.99-1.11)
0.07
Emotional hypersensitivity
0.04
1.04 (0.92-1.17)
0.56
Dizziness
0.04
1.04 (0.91-1.20)
0.55
Palpitations
0.03
1.03 (0.98-1.09)
0.28
Mood swings
0.03
1.03 (0.98-1.09)
0.28
Tendency to cry easily
0.03
1.03 (0.91-1.18)
0.63
Swelling in extremities
0.02
1.02 (0.97-1.08)
0.46
Breast tenderness
0.02
1.02
(0.96-1.08)
0.52
Abdominal bloating
0.01
1.02 (0.96-1.08)
0.63
Acne
0.02
1.02 (0.93-1.12)
0.65
Depression
0.02
1.02 (0.89-1.17)
0.82
Confusion
0.007
1.01 (0.94-1.07)
0.84
Back pain
0.006
1.01 (0.92-1.10)
0.90
Desire to be alone
0.009
1.01 (0.90-1.13)
0.87
Insomnia
-0.003
1.00 (0.92-1.08)
0.95
Diarrhea/constipation
0.00006
1.00 (0.91-1.10)
0.99
Anxiety/nervousness
-0.00998
0.99 (0.92-1.06)
0.78
Fatigue
-0.03
0.97 (0.91-1.03)
0.31
Abdominal cramping
-0.07
0.93 (0.63-1.39)
0.73
Hot flashes
-0.11
0.89 (0.78-1.03)
0.12
Angry outbursts
-0.13
0.88 (0.69-1.11)
0.27
Nausea
-0.14
0.87 (0.74-1.01)
0.07
Headache
*Adjusted for age and history of depression/bipolar disorder
**OR per 10 MET-hour/week increase in physical activity
***For each symptom, analysis compares moderate-severe vs. none-mild severity level
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